Lisa Krows - 02 May 2022 Form 4 Insider Report for CATO CORP (CATO)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
02 May 2022, 21:21:31 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Karen Collins

Key filing fact

Lisa Krows filed Form 4 for CATO CORP (CATO) on 02 May 2022.

Key facts

  • This page summarizes Lisa Krows's Form 4 filing for CATO CORP (CATO).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 May 2022, 21:21.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$5,296.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CATO transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+6,474
Change %
+18%
Price
$0.000000
Shares after
41,786
Date
02 May 2022
Ownership
Direct
Footnotes
F1
CATO transaction

Class A Common Stock

Tax liability

Transaction value
$5,296
Shares
-386
Change %
-0.92%
Price
$13.72
Shares after
41,400
Date
02 May 2022
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Compensation Committee awarded restricted shares on March 23, 2022. The grant was effective May 1, 2022, but the shares remain subject to a time-based vesting schedule.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .